Clinical Trial Update: Sorafenib in Relapsed High Grade Osteosarcoma [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluating sorafenib in patients with relapsed high-grade osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED